Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 406 of the 410 references it cites were found in a registry or an index.

Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)

JBS3 Board·2014·Heart

Abstract

In 1961, the publication of the findings of the Framingham study provided the National Institutes of Health (NIH), the USA, and the world at large with a huge return on the initial investment. Identification of the common risk factors fuelling the epidemic of cardiovascular disease (CVD) stimulated a ‘call to arms’ and the initiation of programmes to attack these targets on a national scale. This has led to stunning declines in CVD mortality over the last 40–50 years in North America, Western Europe and other high income countries. Nonetheless, this is not the time for complacency. CVD is by far and away the leading cause of deaths worldwide; the epidemic of CVD in the low and middle income countries is rampant and the alarming increases in obesity and diabetes threaten to reverse or blunt the steady decline in CVD mortality, particularly in younger people. The focus on prevention is as imperative now as it ever has been. This is the 3rd iteration of the Joint British Societies ( JBS) recommendations for the prevention of cardiovascular disease. Current prevention strategies tend to focus upon patients at relatively short term (10-year) risks and upon specific thresholds for pharmacologic therapies, although there is considerable variability among the different guidelines. This approach is logical and has been successful in directing therapy to those at highest risk who stand to gain the greatest benefit. A unique aspect of JBS3 is the emphasis upon the lifetime risk of CVD events, so as to encompass a large pool of people in the population who have a lower 10-year risk of a CVD event but who nevertheless have a high lifetime event risk. Such predominantly younger patients and women might be excluded from therapy based upon the ‘high risk strategy’, even though they have a high rate of …

Overview

Integrity signals

Registry

Crossref · 10.1136/heartjnl-2014-305693

Cites

406 of 406 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 410 references

Research works printed but not linked: 8

  1. 10.1136/hrt.2005.079988 · DOI · Paper page
  2. Department of Health. Scientific Committee on Tobacco and Health (SCOTH). Secondhand smoke: review of evidence since 1998, November 2004. http://www.smokefreeengland.co.uk/files/scoth_secondhandsmoke.pdf (accessed 8 Aug 2013).
  3. Office of the Surgeon General (US), Office on Smoking and Health (US). The Health Consequence of Smoking . A Report of the Surgeon General, 2004. http://www.ncbi.nlm.nih.gov/books/NBK44695/ (accessed 8 Aug 2013).
  4. PATS Collaborating Group, 1995, Post-stroke antihypertensive treatment study. A preliminary result, Chin Med J (Engl), 108, 710
  5. National Institute for Health and Clinical Excellence. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. Review of NICE technology appraisal guidance 90. NICE technology appraisal guidance 210, December 2010. nice.org.uk/guidance/TA210 (accessed 2 Sep 2013).*
  6. 10.2337/diabetes. · doi:10.2337/diabetes · Paper page
  7. 10.2337/diacare.294798 · doi:10.2337/diacare.294798
  8. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# · doi:10.1002/1529-0131(200112)44:12<2737::aid-art460>3.0.co;2-#

Cited by

See all 608

Metadata

Authors
JBS3 Board
Affiliations
Stroke Association (GB)
Corresponding author
JBS3 Board
Venue
Heart
Publisher
BMJ
Published
2014-03-25
Volume
100
Issue
Suppl 2
Pages
ii1-ii67
ISSN
  • 1355-6037 (ISSN-L)
  • 1468-201X
OpenAlex
W2170652936
Cited by
608
References
410
Citations by year
2026: 9 · 2025: 17 · 2024: 32 · 2023: 39 · 2022: 40 · 2021: 43 · 2020: 58 · 2019: 75 · 2018: 51 · 2017: 60 · 2016: 69 · 2015: 69 · 2014: 45
FWCI
80.22
Type
journal article
Language
en
Open access
closed
Locations
  • Heart (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0611-10273, NF-SI-0510-10055)
  • Medical Research Council (MC_PC_13090)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
cardiovascular disease prevention, lifetime cardiovascular risk, 10-year cardiovascular risk, cardiovascular risk factors, low- and middle-income countries, obesity, diabetes mellitus, women, young adults
MeSH terms
Age Factors, Cardiology, Cardiovascular Diseases, Decision Support Techniques, Humans, Preventive Health Services, Prognosis, Risk Factors, Sex Factors, Societies, Medical, Comorbidity, Risk Assessment, Consensus, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). https://app.cochat.ai/papers/10.1136/heartjnl-2014-305693
The paper
JBS3 Board. (2014). Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. https://doi.org/10.1136/heartjnl-2014-305693

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.